Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

LupusJul 2, 2026 (epub)
Case ReportCardiologyRheumatologyOpen access

Lisa C Harling, Max Wacker, Arjang Ruhparwar et al.

✦ AI-curated · Sources linked

Case in brief

An 18-year-old patient presented with biventricular heart failure and newly diagnosed systemic lupus erythematosus (SLE). After a 6-month history of fatigue and malaise, echocardiography revealed a severely reduced left ventricular ejection fraction of 5%. Endomyocardial biopsy confirmed giant cell myocarditis (GCM). Despite aggressive treatment, including ECMO and immunosuppressive therapy, the patient succumbed to multiorgan failure before transplantation could be performed.

Diagnostic / clinical pearl

Differentiating giant cell myocarditis from lupus myocarditis is crucial due to their differing prognoses and treatment approaches, especially in young patients with rapid cardiac decline.

Why it matters

This case highlights the need for early biopsy in patients with autoimmune conditions presenting with cardiac symptoms to ensure timely and appropriate management.

Source

Published in Lupus. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.